Related Experiment Video
Updated: Aug 3, 2025

Evaluating In Vitro DNA Damage Using Comet Assay
Published on: October 11, 2017
Atorvastatin Can Modulate DNA Damage Repair in Endothelial Cells Exposed to Mitomycin C
Maxim Sinitsky1, Maxim Asanov1, Anna Sinitskaya1
1Laboratory of Genome Medicine, Research Institute for Complex Issues of Cardiovascular Diseases, Kemerovo 650002, Russia.
Abstract:
HMG-CoA reductase inhibitors (statins) are widely used in the therapy of atherosclerosis and have a number of pleiotropic effects, including DNA repair regulation. We studied the cytogenetic damage and the expression of DNA repair genes (DDB1, ERCC4, and ERCC5) in human coronary artery (HCAEC) and internal thoracic artery endothelial cells (HITAEC) in vitro exposed to mitomycin C (MMC) (positive control), MMC and atorvastatin (MMC+Atv), MMC followed by atorvastatin treatment (MMC/Atv) and 0.9% NaCl (negative control). MMC/Atv treated HCAEC were characterized by significantly decreased micronuclei (MN) frequency compared to the MMC+Atv group and increased nucleoplasmic bridges (NPBs) frequency compared to both MMC+Atv treated cells and positive control; DDB1, ERCC4, and ERCC5 genes were upregulated in MMC+Atv and MMC/Atv treated HCAEC in comparison with the positive control. MMC+Atv treated HITAEC were characterized by reduced MN frequency compared to positive control and decreased NPBs frequency in comparison with both the positive control and MMC/Atv group. Nuclear buds (NBUDs) frequency was significantly lower in MMC/Atv treated cells than in the positive control. The DDB1 gene was downregulated in the MMC+Atv group compared to the positive control, and the ERCC5 gene was upregulated in MMC/Atv group compared to both the positive control and MMC+Atv group. We propose that atorvastatin can modulate the DNA damage repair response in primary human endothelial cells exposed to MMC in a cell line- and incubation scheme-dependent manner that can be extremely important for understanding the fundamental aspects of pleoitropic action of atorvastatin and can also be used to correct the therapy of patients with atherosclerosis characterized by a high genotoxic load.
Insights
Atorvastatin modulates DNA repair in human endothelial cells differently based on treatment timing and cell type. This finding is crucial for understanding statin side effects and treating atherosclerosis patients with high genotoxic load.
Area of Science:
- Cardiovascular Biology
- Molecular Biology
- Genetics
Background:
- HMG-CoA reductase inhibitors (statins) are key in atherosclerosis therapy.
- Statins exhibit pleiotropic effects, including DNA repair regulation.
- Understanding these effects is vital for patient treatment.
Purpose of the Study:
- To investigate the impact of atorvastatin on DNA damage and repair gene expression in human endothelial cells exposed to mitomycin C.
- To determine if atorvastatin's effects are dependent on cell type and incubation strategy.
Main Methods:
- Human coronary artery endothelial cells (HCAEC) and internal thoracic artery endothelial cells (HITAEC) were exposed to mitomycin C (MMC) with or without atorvastatin (Atv).
- Cytogenetic damage (micronuclei, nucleoplasmic bridges, nuclear buds) and DNA repair gene expression (DDB1, ERCC4, ERCC5) were analyzed.
- Different incubation schemes (co-treatment vs. sequential treatment) were employed.
Main Results:
- Atorvastatin modulated DNA damage markers (micronuclei, nucleoplasmic bridges) in a cell- and incubation-dependent manner.
- Expression of DNA repair genes (DDB1, ERCC4, ERCC5) varied significantly between treatment groups and cell types.
- Specific gene expression patterns (e.g., DDB1 downregulation, ERCC5 upregulation) were observed under different atorvastatin treatment conditions.
Conclusions:
- Atorvastatin's modulation of DNA damage repair in endothelial cells is complex and context-specific.
- Findings highlight the importance of considering incubation schemes and cell types in statin therapy.
- This research contributes to understanding statin's pleiotropic actions and optimizing atherosclerosis treatment in genotoxic conditions.
Related Concept Videos
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Overview of DNA Repair
Chemically...
Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...

